GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achilles Therapeutics PLC (FRA:698) » Definitions » Interest Received

Achilles Therapeutics (FRA:698) Interest Received


View and export this data going back to 2021. Start your Free Trial

What is Achilles Therapeutics Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.


Achilles Therapeutics Business Description

Traded in Other Exchanges
Address
245 Hammersmith Road, London, GBR, W6 8PW
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.